PATENT CLAIM ANALYSIS

Application Number: 16047965
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "452000"]

Abstract:
A pharmaceutical composition comprises a solid amorphous dispersion comprising a low-solubility drug and a concentration-enhancing polymer and a lipophilic microphase-forming material. Alternatively, a solid amorphous dispersion comprising a low-solubility drug and a concentration-enhancing polymer is co-administered with a lipophilic microphase-forming material to an in vivo use environment.

Claim (Index 9):
The composition of  claim 1 , wherein the amphiphilic material is a sulfonated hydrocarbon or a salt thereof.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 95.0
- Lexical Diversity: 1.72414
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11924988', '10910448', '13915311', '14331172', '11421888']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7164763823089699
- 35 USC 102 Novelty (BERT): 0.550917643364926
- Combined Prediction Score: 0.6999205084145657
- Mean Citation Score: 266.93142400000005
- Max Citation Score: 419.6932
- Similarity Product: 236.6646176834345

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test